Financials
Income statement
Fiscal date | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 |
---|---|---|---|---|
Total reported revenue | 1.3B | 1.3B | 1.2B | 1.2B |
Cost of revenue | 478M | 485M | 462M | 453M |
Gross profit | 820M | 802M | 755M | 763M |
Operating expense | ||||
Research & development | 249M | 233M | 226M | 228M |
Selling general and admin | 361M | 343M | 329M | 361M |
Other operating expenses | -8M | -4M | -5M | -3M |
Operating income | 218M | 230M | 205M | 177M |
Non operating interest income | ||||
Income | 19M | 21M | 19M | 18M |
Expense | 20M | 23M | 21M | 20M |
Other income expense | -18M | 20M | 10M | — |
Pretax income | 199M | 248M | 213M | 175M |
Tax provision | 30M | 321M | -176M | 49M |
Net income | 169M | -73M | 389M | 126M |
Basic EPS | 1.0 | -0.4 | 2.2 | 0.7 |
Diluted EPS | 1.0 | -0.4 | 2.2 | 0.7 |
Basic average shares | 173M | 173M | 174M | 174M |
Diluted average shares | 174M | 173M | 175M | 175M |
EBITDA | 285M | 339M | 298M | 265M |
Net income from continuing op. | 169M | -73M | 389M | 126M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |